Chemart Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -30.28%
- Profit Growth 186.12%
- Ebitda 113.51%
- Net Worth 184.06%
- Total Assets -21.12%
About Chemart Pharma
Chemart Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 August 2020 (Four years and five months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alla Reddy, Vishnu Kowkuntla, and Saketh Pailla serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52520TG2020PTC142822
-
Company No.
142822
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Chemart Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alla Reddy
|
Director | 14-Aug-2020 | Current |
|
Vishnu Kowkuntla
|
Director | 14-Aug-2020 | Current |
Saketh Pailla
|
Additional Director | 28-Dec-2021 | Current |
Financial Performance of Chemart Pharma.
Chemart Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.28% decrease. The company also saw a substantial improvement in profitability, with a 186.12% increase in profit. The company's net worth Soared by an impressive increase of 184.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemart Pharma?
Unlock access to Chemart Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Smart Agro Industries Corporation Private LimitedVishnu Kowkuntla and Saketh Pailla are mutual person
-
Smart Agro Food Park Private LimitedSaketh Pailla is a mutual person
-
Sciegen Pharmaceuticals India Private LimitedAlla Reddy and Saketh Pailla are mutual person
-
Chemeca Drugs Private LimitedAlla Reddy and Saketh Pailla are mutual person
-
Bactolac Nutraceuticals Private LimitedAlla Reddy and Saketh Pailla are mutual person
-
Azura Plastics Private Limited
Alla Reddy and Saketh Pailla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemart Pharma?
Chemart Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemart Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemart Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.